Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. CON
stocks logo

CON

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent
Wall Street analysts forecast CON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CON is 29.00 USD with a low forecast of 27.00 USD and a high forecast of 31.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast CON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CON is 29.00 USD with a low forecast of 27.00 USD and a high forecast of 31.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 19.540
sliders
Low
27.00
Averages
29.00
High
31.00
Current: 19.540
sliders
Low
27.00
Averages
29.00
High
31.00
UBS
Neutral
maintain
$38 -> $52
2025-10-14
Reason
UBS
Price Target
$38 -> $52
2025-10-14
maintain
Neutral
Reason
UBS raised the firm's price target on Concentra to $52 from $38 and keeps a Neutral rating on the shares.
JPMorgan
Benjamin Rossi
Overweight
initiated
$31
2025-09-18
Reason
JPMorgan
Benjamin Rossi
Price Target
$31
2025-09-18
initiated
Overweight
Reason
JPMorgan analyst Benjamin Rossi assumed coverage of Concentra with an Overweight rating and unchanged $31 price target. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. Concentra is the analyst's top pick among outpatient names given the company's lower exposure to federal spending programs.
JP Morgan
Lisa Gill
Buy
Maintains
$29 → $30
2025-03-19
Reason
JP Morgan
Lisa Gill
Price Target
$29 → $30
2025-03-19
Maintains
Buy
Reason
JPMorgan analyst Lisa Gill raised the firm's price target on Concentra to $30 from $29 and keeps an Overweight rating on the shares. Following Q4 earnings, the firm is updating its estimates, noting that for 2025 it increased its revenue estimate to $2.115B and its adjusted EBITDA estimate to $420M while also increasing its 2026 revenue and adjusted EBITDA estimates.
RBC Capital
Ben Hendrix
Buy
Reiterates
$30
2025-01-23
Reason
RBC Capital
Ben Hendrix
Price Target
$30
2025-01-23
Reiterates
Buy
Reason
B of A Securities
Joanna Gajuk
Strong Buy
Maintains
$24 → $25
2025-01-23
Reason
B of A Securities
Joanna Gajuk
Price Target
$24 → $25
2025-01-23
Maintains
Strong Buy
Reason
BofA raised the firm's price target on Concentra to $25 from $24 and keeps a Buy rating on the shares after the company announced an agreement to acquire Nova Medical Centers for $265M, pre-announced Q4 results, and provided 2025 guide that was roughly in line with consensus excluding the Nova deal contribution. The firm raised its estimates for a better Q4 and the deal and raised its multiple given the increased visibility into estimates.
B of A Securities
Joanna Gajuk
Hold
to
Strong Buy
Upgrades
$24
2024-12-16
Reason
B of A Securities
Joanna Gajuk
Price Target
$24
2024-12-16
Upgrades
Hold
to
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Concentra Group Holdings Parent Inc (CON.N) is 13.54, compared to its 5-year average forward P/E of 16.38. For a more detailed relative valuation and DCF analysis to assess Concentra Group Holdings Parent Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
16.38
Current PE
13.54
Overvalued PE
18.31
Undervalued PE
14.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.72
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.51
Undervalued EV/EBITDA
9.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.30
Current PS
0.00
Overvalued PS
1.42
Undervalued PS
1.18
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

CON News & Events

Events Timeline

(ET)
2025-11-10
16:32:41
Concentra Appoints Jason Cooper as Chief Officer of Data, Analytics, and AI
select
2025-08-07 (ET)
2025-08-07
16:34:00
Concentra sees FY25 revenue $2.13B-$2.16B, consensus $2.13B
select
2025-08-07
16:33:31
Concentra reports 2Q adjusted EPS 37c, consensus 38c
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
11-11Newsfilter
Concentra Names Jason Cooper as Chief Officer for Data, Analytics, and Artificial Intelligence
  • Appointment of Jason Cooper: Concentra has appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer to align the company's data strategy with growth priorities.

  • Expertise and Experience: Cooper brings over 25 years of experience in data and technology across various sectors, including roles at L3-Communications, CVS Caremark, and Cigna.

  • Focus on Data-Driven Outcomes: Cooper aims to enhance Concentra's data governance and AI initiatives, building on the company's established reputation as an innovator in occupational health services.

  • Concentra's Mission: As the largest provider of occupational health services in the U.S., Concentra serves over 50,000 patients daily through its extensive network of health centers and clinics.

[object Object]
Preview
6.0
11-07WSJ
Chips Previously Stalled by Trade War Begin to Reach Auto Suppliers Again
  • Nexperia Microchips: Nexperia microchips are being shipped from China, helping to alleviate a shortage of essential components for the automotive industry.

  • Aumovio's Role: Aumovio, a new automotive supplier spun off from Continental, is receiving these semiconductors at its distribution hub in Hungary.

[object Object]
Preview
2.0
11-05NASDAQ.COM
Strength Alert Issued for Parent Company of Concentra Group Holdings
  • Stock Performance: Concentra Group Holdings Parent Inc (CON) shares have entered oversold territory, with an RSI reading of 28.5, indicating potential buying opportunities for investors.

  • Dividend Yield: The stock currently offers an annualized dividend of $0.25 per share, translating to a yield of 1.29% based on a share price of $19.36.

  • Investor Sentiment: The low RSI suggests that heavy selling may be exhausting, prompting bullish investors to consider entry points for purchasing the stock.

  • Dividend History Importance: Investors are encouraged to review CON's dividend history to assess the likelihood of continued dividend payments, as dividends can be unpredictable.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Concentra Group Holdings Parent Inc (CON) stock price today?

The current price of CON is 19.54 USD — it has increased 0.1 % in the last trading day.

arrow icon

What is Concentra Group Holdings Parent Inc (CON)'s business?

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.

arrow icon

What is the price predicton of CON Stock?

Wall Street analysts forecast CON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CON is 29.00 USD with a low forecast of 27.00 USD and a high forecast of 31.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Concentra Group Holdings Parent Inc (CON)'s revenue for the last quarter?

Concentra Group Holdings Parent Inc revenue for the last quarter amounts to 572.80M USD, increased 16.98 % YoY.

arrow icon

What is Concentra Group Holdings Parent Inc (CON)'s earnings per share (EPS) for the last quarter?

Concentra Group Holdings Parent Inc. EPS for the last quarter amounts to 0.37 USD, decreased 0.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Concentra Group Holdings Parent Inc (CON)'s fundamentals?

The market is revising Upward the revenue expectations for Concentra Group Holdings Parent, Inc. (CON) for FY2025, with the revenue forecasts being adjusted by 0.19% over the past three months. During the same period, the stock price has changed by -15.37%.
arrow icon

How many employees does Concentra Group Holdings Parent Inc (CON). have?

Concentra Group Holdings Parent Inc (CON) has 8758 emplpoyees as of December 05 2025.

arrow icon

What is Concentra Group Holdings Parent Inc (CON) market cap?

Today CON has the market capitalization of 2.50B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free